Number of the records: 1

chemokín CCL5

SYS		d018946
LBL		00000cz--a2200000n--4500
005		20250606212954.1
008		950221\|\|\|anznnbabn-----------\|-a\|a------
040		$b slo $a DNLM $d BA006 $d BA006
065		$a D12.644.276.374.200.110.250
065		$a D12.776.467.374.200.110.250
065		$a D23.125.300.110.250
065		$a D23.469.200.110.250
065		$a D23.529.374.200.110.250
066		$a 01 $c 03
150		$a chemokín CCL5 $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo
450		$w v $a CCL5 Chemokine $2 eng
450		$w v $a RANTES $2 eng
450		$w v $a RANTES $2 slo
665		$a 2008(1996) $2 eng
665		$a Lymphokines (1988-1995) $2 eng
680	9-	$i A CC-type chemokine that is a chemoattractant for EOSINOPHILS; MONOCYTES; and LYMPHOCYTES. It is a potent and selective eosinophil chemotaxin that is stored in and released from PLATELETS and activated T-LYMPHOCYTES. Chemokine CCL5 is specific for CCR1 RECEPTORS; CCR3 RECEPTORS; and CCR5 RECEPTORS. The acronym RANTES refers to Regulated on Activation, Normal T Expressed and Secreted. $2 eng
750	-2	$a Chemokine CCL5 $2 eng
980		$x M

Number of the records: 1